Effects of 12-Week Methylphenidate Treatment on Neurometabolism in Adult Patients with ADHD: The First Double-Blind Placebo-Controlled MR Spectroscopy Study

Effects of 12-Week Methylphenidate Treatment on Neurometabolism in Adult Patients with ADHD: The First Double-Blind Placebo-Controlled MR Spectroscopy Study

Attention deficit hyperactivity disorder (ADHD) is a frequent neurodevelopmental disorder that often persists into adulthood. Methylphenidate (MPH) is the first-line treatment for ADHD; however, despite its wide usage, little is known about its neurometabolic effects. Until now, no randomized and bl...

Full description

Bibliographic Details
Main Authors: Simon Maier, Ludger Tebartz van Elst, Alexandra Philipsen, Thomas Lange, Bernd Feige, Volkmar Glauche, Kathrin Nickel, Swantje Matthies, Barbara Alm, Esther Sobanski, Katharina Domschke, Evgeniy Perlov, Dominique Endres
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Journal of Clinical Medicine
Subjects:
ADHD
MR spectroscopy
MRS
methylphenidate
glutamate
Online Access:https://www.mdpi.com/2077-0383/9/8/2601

Internet

https://www.mdpi.com/2077-0383/9/8/2601

Similar Items